U-Neuron Biomedical Stock

U-Neuron Biomedical Net Margin

The Net Profit Margin of U-Neuron Biomedical (6973.TWO) as of Aug 1, 2026 is -129.77 %. In the previous year, Net Profit Margin was -314.14 % — a change of -58.69% (higher).

Net Margin

-129.77 %

YoY

-58.69%

Last updated:

Net Profit Margin of U-Neuron Biomedical is 2026 -129.77 % . Net Profit Margin of U-Neuron Biomedical was 2025 -314.14 % . It decreases by -58.69% higher compared to the previous year.

For U-Neuron Biomedical, the net margin of -129.8% is down versus -39.6% a few years ago.

Access this data via the Eulerpool API

U-Neuron Biomedical Stock analysis

What does U-Neuron Biomedical do? U-Neuron Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about U-Neuron Biomedical stock

Net Profit Margin of U-Neuron Biomedical is -129.77 % in 2026.

Access this data via the Eulerpool API

Margins — U-Neuron Biomedical

All Key Metrics — U-Neuron Biomedical